Satomi Idenoue

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Tetsuhiro Tsuruma, Fumitake Hata, Toshihiko Torigoe et al. · Journal of Translational Medicine · 2004 · 181 citations · Full text

Medicine, Immunology, Oncology +17

A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins

Satomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Clinical Cancer Research · 2005 · 121 citations · Full text

Life Sciences, Immunology, Oncology +17

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients

Jun’ichi Kobayashi, Toshihiko Torigoe, Yoshihiko Hirohashi et al. · Journal of Translational Medicine · 2009 · 119 citations · Full text

Medicine, Immunology, Oncology +17